VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,392,128 | -48.1% | 497,665 | -49.4% | 0.60% | +6.2% |
| Q2 2023 | $25,805,822 | +6952.5% | 984,488 | +5902.2% | 0.57% | +3443.8% |
| Q1 2023 | $365,911 | +45298.4% | 16,402 | -54.8% | 0.02% | -27.3% |
| Q4 2022 | $806 | -99.9% | 36,259 | -8.1% | 0.02% | -4.3% |
| Q3 2022 | $879,000 | +12.1% | 39,435 | +12.2% | 0.02% | -8.0% |
| Q2 2022 | $784,000 | -8.9% | 35,155 | -8.8% | 0.02% | +127.3% |
| Q1 2022 | $861,000 | +2000.0% | 38,537 | +3051.0% | 0.01% | +1000.0% |
| Q4 2021 | $41,000 | -54.9% | 1,223 | -59.6% | 0.00% | -50.0% |
| Q3 2021 | $91,000 | -68.1% | 3,030 | -63.8% | 0.00% | -66.7% |
| Q2 2021 | $285,000 | +190.8% | 8,376 | +179.8% | 0.01% | +200.0% |
| Q1 2021 | $98,000 | -52.2% | 2,994 | -48.0% | 0.00% | -75.0% |
| Q4 2020 | $205,000 | -78.6% | 5,754 | -76.7% | 0.01% | -86.0% |
| Q3 2020 | $958,000 | +20.5% | 24,669 | +8.7% | 0.06% | -9.5% |
| Q2 2020 | $795,000 | +846.4% | 22,686 | +592.3% | 0.06% | +687.5% |
| Q1 2020 | $84,000 | -99.2% | 3,277 | -99.1% | 0.01% | -99.0% |
| Q4 2019 | $10,317,000 | +18.0% | 357,716 | +12.4% | 0.78% | +32.3% |
| Q3 2019 | $8,740,000 | +836.8% | 318,344 | +663.2% | 0.59% | +361.4% |
| Q1 2019 | $933,000 | +34.6% | 41,713 | +23.9% | 0.13% | +202.4% |
| Q4 2018 | $693,000 | -1.4% | 33,660 | -11.3% | 0.04% | +44.8% |
| Q3 2018 | $703,000 | -40.7% | 37,956 | -28.5% | 0.03% | -42.0% |
| Q2 2018 | $1,185,000 | +40.4% | 53,096 | +46.2% | 0.05% | +31.6% |
| Q1 2018 | $844,000 | 0.0% | 36,326 | 0.0% | 0.04% | 0.0% |
| Q4 2017 | $844,000 | -9.9% | 36,326 | -11.0% | 0.04% | +2.7% |
| Q3 2017 | $937,000 | +5.8% | 40,824 | +1.8% | 0.04% | -2.6% |
| Q2 2017 | $886,000 | -5.7% | 40,116 | -2.7% | 0.04% | -7.3% |
| Q1 2017 | $940,000 | -30.4% | 41,215 | -36.2% | 0.04% | -36.9% |
| Q4 2016 | $1,351,000 | -65.8% | 64,600 | -56.8% | 0.06% | -68.4% |
| Q3 2016 | $3,955,000 | +17.1% | 149,640 | +22.8% | 0.21% | +9.0% |
| Q2 2016 | $3,377,000 | +262.0% | 121,886 | +192.2% | 0.19% | +48.8% |
| Q1 2016 | $933,000 | – | 41,713 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |